CHOLESTATIC LIVER DISEASE
Clinical trials for CHOLESTATIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHOLESTATIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for CHOLESTATIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a vitamin d cocktail fix deficiency in kids with liver disease?
Disease control Recruiting nowThis study tests whether adding calcitriol to vitamin D2 helps children with cholestatic liver disease correct their vitamin D deficiency faster than vitamin D2 alone. Cholestasis makes it hard for the body to absorb vitamin D. The trial will enroll 54 children and track vitamin …
Matched conditions: CHOLESTATIC LIVER DISEASE
Phase: PHASE4 • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Gene hunt for mysterious adult liver disease
Knowledge-focused Recruiting nowThis study is using advanced whole-genome sequencing to find hidden genetic causes of cholestatic liver disease in adults whose condition remains unexplained after standard tests. Researchers will compare the DNA of 60 affected adults to a large group of healthy controls. The goa…
Matched conditions: CHOLESTATIC LIVER DISEASE
Phase: NA • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Liver drug study seeks to understand how body processes medication in scarred livers
Knowledge-focused Recruiting nowThis study looks at how the drug Saroglitazar is processed in people with mild, moderate, or severe liver scarring (cirrhosis) caused by cholestatic liver disease. About 30 adults will take the drug once daily for 28 days. The goal is to measure drug levels in the blood and check…
Matched conditions: CHOLESTATIC LIVER DISEASE
Phase: PHASE1 • Sponsor: Zydus Therapeutics Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New drug study aims to understand how liver disease affects medication
Knowledge-focused Recruiting nowThis early-stage study will test a drug called saroglitazar magnesium in 6 adults with moderate liver scarring (cirrhosis) caused by cholestatic liver disease. The main goal is to see how the drug moves through the body and if it is safe when taken every other day. Participants w…
Matched conditions: CHOLESTATIC LIVER DISEASE
Phase: PHASE1 • Sponsor: Zydus Therapeutics Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC